Physician profile
Scott M Killmer
NPI 1831196542
$2,574.87
in general payments reported to CMS, 2019-2025
10 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $14.06 · 2021: $44.99 · 2022: $174 · 2023: $445 · 2024: $903 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,607.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,045.42 | 2019-2024 | Phasix Mesh |
| Intuitive Surgical, INC. | $898.03 | 2019-2025 | Da Vinci Surgical System |
| Cvrx, INC. | $259.72 | 2024 | Barostim Neo System |
| Organogenesis INC. | $186.84 | 2022-2024 | Puraply Wound Matrix |
| Hologic Sales and Service, LLC | $75.30 | 2022-2023 | Atec |
| Integra Lifesciences Corporation | $44.99 | 2021 | |
| Smith+Nephew, INC. | $23.97 | 2024 | Stravix |
| Novartis Pharmaceuticals Corporation | $14.06 | 2020 | |
| Capsovision, INC. | $13.58 | 2025 | Capsocam Plus |
| Medtronic, INC. | $12.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Killmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.